Tunde Sotunde - 01 Nov 2021 Form 4 Insider Report for Evolent Health, Inc. (EVH)

Role
Director
Signature
/s/ Jonathan Weinberg, Attorney-in-fact
Issuer symbol
EVH
Transactions as of
01 Nov 2021
Net transactions value
$0
Form type
4
Filing time
03 Nov 2021, 17:01:56 UTC
Previous filing
03 Nov 2021
Next filing
13 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EVH Class A Common Stock Award $0 +3,405 $0.000000 3,405 01 Nov 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units granted to Dr. Sotunde pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
F2 Securities vest on the earlier of November 1, 2022 and the date of the company's 2022 annual meeting, subject to the reporting person's continued service on the vesting date.